DrugPatentWatch Database Preview
Drugs in Development Information for LIK066
Email this page to a colleague
» See Plans and PricingWhat is the drug development status for LIK066?
LIK066 is an investigational drug.
There have been 12 clinical trials for LIK066.
The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2015.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Non-alcoholic Fatty Liver Disease. The leading clinical trial sponsors are Novartis Pharmaceuticals and [disabled in preview].
There are six US patents protecting this investigational drug and eighty international patents.
Summary for LIK066
| US Patents | 6 |
| International Patents | 80 |
| US Patent Applications | 8 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2015-06-01) |
| Vendors | 8 |
Recent Clinical Trials for LIK066
| Title | Sponsor | Phase |
|---|---|---|
| Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin Compared to Each Monotherapy, in Adult Patients With NASH and Liver Fibrosis. | Novartis Pharmaceuticals | Phase 2 |
| A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity | Novartis Pharmaceuticals | Phase 2 |
| Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients | Novartis Pharmaceuticals | Phase 2 |
Clinical Trial Summary for LIK066
Top disease conditions for LIK066
Top clinical trial sponsors for LIK066
US Patents for LIK066
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| LIK066 | Start Trial | C-aryl glucoside derivative, preparation methods thereof, and medical applications thereof | YOUNGENE THERAPEUTICS CO., LTD (China (Shanghai) Pilot Free Trade Zone, CN) | Start Trial |
| LIK066 | Start Trial | Glycoside derivatives and uses thereof | Novartis AG (Basel, CH) | Start Trial |
| LIK066 | Start Trial | Glycoside derivatives and uses thereof | Novartis AG (Basel, CH) | Start Trial |
| LIK066 | Start Trial | Glycoside derivatives and uses thereof | Novartis AG (Basel, CH) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for LIK066
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| LIK066 | Australia | 2014317663 | 2033-09-09 | Start Trial |
| LIK066 | Canada | 2923522 | 2033-09-09 | Start Trial |
| LIK066 | China | 105518014 | 2033-09-09 | Start Trial |
| LIK066 | China | 107311992 | 2033-09-09 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
